pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
300
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
INVA-8001
Atopic Dermatitis (Atopic Eczema)
Invea Therapeutics Inc
0
catalysts
Phase 2
ISN-001
Diabetic Foot Ulcers
Anterogen Co Ltd
0
catalysts
Preclinical
ITR-2401
Androgenic Alopecia
Solipharma LLC
0
catalysts
Preclinical
KPV
Inflammation
PharmaTher Holdings Ltd
← prev
page 5 of 10
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 2
KT-621
Eosinophilic Asthma
$KYMR
Kymera Therapeutics, Inc.
0
catalysts
Marketed
Klaron
Sulfacetamide Sodium Oceanside (sulfacetamide sodium)
Acne Vulgaris
Bausch Health Americas Inc
0
catalysts
Phase 2
LUT-014
Acne And Related Disorders
Lutris Pharma
0
catalysts
Preclinical
LUT-017
Wounds
Lutris Pharma
0
catalysts
Phase 2
MC-232
Hidradenitis Suppurativa
MC2 Therapeutics AS
0
catalysts
Phase 2
MDI-1228
Diabetic Foot Ulcers
Henan Maiyingnuo Pharmaceutical Technology Co Ltd
0
catalysts
Phase 1
MEI-004
Alopecia
Nanjing Mainowei Pharmaceutical Technology Co Ltd.
0
catalysts
Phase 2
MTX-001
Venous Leg Ulcers (Crural Ulcer)
Merakris Therapeutics Inc
0
catalysts
Preclinical
MVREX-101
Wounds
Immvira Co Ltd
0
catalysts
Preclinical
MVREX-104
Androgenic Alopecia
Immvira Co Ltd
0
catalysts
Phase 2
NanoDOX
Wounds
Resilience Government Services Inc
0
catalysts
Marketed
Nizoral
Ketoconazole Patriot (ketoconazole)
Pityriasis Simplex Capillitii (Dandruff)
Patriot Pharmaceuticals LLC
0
catalysts
Phase 2
Nu-3
Diabetic Foot Ulcers
Lakewood-Amedex Inc
0
catalysts
Phase 2
NuGel
Atopic Dermatitis (Atopic Eczema)
Hudson Therapeutics Inc
0
catalysts
Preclinical
NvA-011
Dystrophic Epidermolysis Bullosa
Nova Anchora LLC
0
catalysts
Phase 2
OLX-101A
Hypertrophic Scars
OliX Pharmaceuticals Inc
0
catalysts
Marketed
Opzelura
Opzelura (ruxolitinib phosphate)
Hidradenitis Suppurativa
Tyrosine-protein kinase JAK1
Tyrosine-protein kinase JAK2
$INCY
INCYTE CORP
0
catalysts
Phase 2
P-12
Burns
Penicillin-binding protein
NeoMatrix Therapeutics Inc
0
catalysts
Phase 1
PF-07832837
Atopic Dermatitis (Atopic Eczema)
$PFE
PFIZER INC
0
catalysts
Phase 2
PH-10
Xantryl
Atopic Dermatitis (Atopic Eczema)
$PVCT
PROVECTUS BIOPHARMACEUTICALS, INC.
0
catalysts
Phase 1
PTH-0300
Atopic Dermatitis (Atopic Eczema)
Protheragen Inc
0
catalysts
Phase 3
QRX-003
Netherton Syndrome (Bamboo Hair)
$QNRX
Quoin Pharmaceuticals, Ltd.
0
catalysts
Phase 1
QX-027N
Chronic Obstructive Pulmonary Disease (COPD)
Windward Bio AG
0
catalysts
Preclinical
QX-035N
Unspecified Respiratory Disorders
JiangSu Qyuns Therapeutics Co Ltd
0
catalysts
Phase 1
REX-8756
Asthma
Recludix Pharma Inc
0
catalysts
Phase 2
RLF-TD011
Dystrophic Epidermolysis Bullosa
$RLFTY
MindMaze Therapeutics Holding SA
0
catalysts
